Two Cases of Alopecia Universalis
E. G. Graham Little
openalex +4 more sources
Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient. [PDF]
Giavina-Bianchi M, Giavina-Bianchi P.
europepmc +2 more sources
Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis. [PDF]
Call JE, Sahni S, Zug KA.
europepmc +3 more sources
Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report. [PDF]
Todberg T, Loft ND, Zachariae C.
europepmc +3 more sources
Alopecia areata: a multifactorial autoimmune condition [PDF]
Alopecia areata is an autoimmune disease that results in non-scarring hair loss, and it is clinically characterised by small patches of baldness on the scalp and/or around the body. It can later progress to total loss of scalp hair (Alopecia totalis) and/
Butcher, John P. +3 more
core +1 more source
JAK3 as an emerging target for topical treatment of inflammatory skin diseases [PDF]
The recent interest and elucidation of the JAK/STAT signaling pathway created new targets for the treatment of inflammatory skin diseases (ISDs). JAK inhibitors in oral and topical formulations have shown beneficial results in psoriasis and alopecia ...
Alves de Medeiros, Ana +5 more
core +2 more sources
Emerging Topical and Systemic JAK Inhibitors in Dermatology [PDF]
Accumulating data on cellular and molecular pathways help to develop novel therapeutic strategies in skin inflammation and autoimmunity. Examples are psoriasis and atopic dermatitis, two clinically and immunologically well-defined disorders.
Ghoreschi, Kamran +2 more
core +1 more source
Establishing and Prioritising Research Questions for the Treatment of Alopecia Areata: The Alopecia Areata Priority Setting Partnership [PDF]
BACKGROUND: Alopecia areata is a common hair loss disorder that results in patchy to complete hair loss. Many uncertainties exist around the most effective treatments for this condition. OBJECTIVES: To identify uncertainties in alopecia areata management
Brockley, J.R. +14 more
core +2 more sources
Retrospective review of diphencyprone in the treatment of alopecia areata [PDF]
Contact immunotherapy with diphencyprone (DCP) is used to treat alopecia areata (AA). Its reported efficacy is variable, and individual response cannot be predicted.
Holmes, S., Lamb, R. C., Young, D.
core +1 more source
Successful treatment of alopecia universalis with abrocitinib: a case report
Abrocitinib, a highly selective inhibitor of Janus kinase 1 (JAK1), has been approved for the treatment of moderate-to-severe atopic dermatitis (AD).
J. Zhang, Y. Zuo
semanticscholar +1 more source

